Biocomposites acquires remaining shares in manufacturers of SYNICEM™ and Subiton products
SYNICEM™ and Subiton antibiotic bone cements and preformed antibiotic-loaded spacers support surgeons’ infection treatment strategiesLaboratorios SL S.A. and Synergie Ingénierie Médicale S.A.R.L. are the manufacturers of SYNICEM™ and Subiton products
Keele, UK, 18 September 2024 – Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, is pleased to announce the acquisition of the remaining shares in Laboratorios SL S.A. and Synergie Ingénierie Médicale S.A.R.L. – gaining full control of the SYNICEMTM and Subiton product ranges.
